novo nordisk reuters - Search News

News

Novo Nordisk to Expand Access to Wegovy

Reuters on MSN · 1d

Novo Nordisk says WeightWatchers will sell Wegovy, announces $299 price

The partnership helps Novo capture patients who have been using compounded versions of the medicine, while allowing WeightWatchers to reboot its drug strategy.

The Wall Street Journal on MSN · 1d

Novo Nordisk to Expand Access to Wegovy with WeightWatchers Partnership

The pharmaceutical giant said WeightWatchers will work with CenterWell Pharmacy to fulfill and deliver Wegovy prescriptions.

Seeking Alpha on MSN · 1d

Novo Nordisk taps WeightWatchers for Wegovy after exiting Hims & Hers deal

Novo Nordisk (NVO) has partnered with WeightWatchers (OTC:WGHTQ) to sell its obesity drug Wegovy days after exiting a similar deal with Hims & Hers Health (NYSE:HIMS) that gave the telehealth firm direct access to the company's blockbuster GLP-1 therapy.

22hon MSN

Health Rounds: Novo Nordisk's semaglutide may help some with type 1 diabetes

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

4don MSN

Novo Exits Hims Partnership, Citing Concerns Over Compounded Drugs

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results